- wellness@asiamedic.com.sg
- +6567898888
-
Mon - Fri: 8:30am - 5:30pm
Sat: 8:30am - 12:30pm
Sun & PH: Closed
News
News
Change - Announcement Of Appointment Of Alternate Non-Executive Director
BackAug 11, 2020
| Announcement Title | Change - Announcement of Appointment |
| Date & Time of Broadcast | Aug 11, 2020 17:29 |
| Status | New |
| Announcement Sub Title | APPOINTMENT OF ALTERNATE NON-EXECUTIVE DIRECTOR |
| Announcement Reference | SG200811OTHRZVT9 |
| Submitted By (Co./ Ind. Name) | Stanley Woo |
| Designation | Group Financial Controller |
| Description (Please provide a detailed description of the event in the box below) | Sponsor statement: This announcement has been reviewed by the Company's Sponsor, Xandar Capital Pte Ltd, in compliance with Rule 226 of the Catalist Rules. It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) at 3 Shenton Way, #24-02 Shenton House, Singapore 068805. Telephone number: (65) 63194954. |
| Additional Details | |
| Date Of Appointment | 12/08/2020 |
| Name Of Person | Joelle Lee Siew Hong |
| Age | 49 |
| Country Of Principal Residence | Singapore |
| The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) | The Nominating Committee has reviewed the credentials and experience of Ms Joelle Lee and recommended her appointment as Alternate Director to Mr Charles Wang. The Board of Directors has accepted and approved her appointment based on the recommendation of the Nominating Committee. |
| Whether appointment is executive, and if so, the area of responsibility | The appointment is non-executive. |
| Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Alternate Non-Executive Director to Mr Charles Wang Chong Guang (Non-Executive Chairman) |
| Professional qualifications | Master Degree, National University of Singapore Bachelor Degree, University of Southern Queensland Advanced Diploma, Nanyang Polytechnic, Singapore General Nursing Certificate, Singapore Certificate, Health Insurance Underwriting, Singapore Critical Care, Disaster & Trauma Certificate, Harvard Medical International Boston, USA, Disaster Management Certificate, Israel |
| Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries | Ms Lee is the Singapore Chief Executive Officer of the Luye Medical Group. Luye Medical Group is an associate of Luye Medical Group Pte Ltd, the controlling shareholder of AsiaMedic Limited |
| Conflict of interests (including any competing business) | No |
| Working experience and occupation(s) during the past 10 years | Feb 2020 - Present Singapore Chief Executive Officer, Luye Medical Group 2017 - 2020 Chief of Health, NTUC Income Insurance 2016 - 2017 Director, Healthcare, KPMG Singapore Pte Ltd 2014 - 2016 Director, Operations & Administration, Tan Tock Seng Hospital 2011 - 2014 Senior Director, Fortis Healthcare 2009 - 2011 Deputy Director, Dental & Nursing Division, National Healthcare Polyclinic Deputy Director, Clinical Project Management & Planning National Healthcare Group HQ (concurrent appointment) |
| Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) | Yes |
| Shareholding interest in the listed issuer and its subsidiaries? | No |
| # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8). | |
| Past (for the last 5 years) | DaVita Singapore Pte Ltd |
| Present | Nil |
| (a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? | No |
| (b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | No |
| (c) Whether there is any unsatisfied judgment against him? | No |
| (d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | No |
| (e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | No |
| (f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | No |
| (g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | No |
| (h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | No |
| (i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | No |
| (j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- | |
| (i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | No |
| (ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | No |
| (iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | No |
| (iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | No |
| (k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | No |
| Any prior experience as a director of an issuer listed on the Exchange? | No |
| If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange | Ms Lee will attend training on the roles and responsibilities of a director of a listed company |